ProfileGDS4132 / 231873_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 77% 76% 76% 81% 76% 80% 78% 79% 82% 79% 82% 83% 80% 80% 81% 83% 82% 87% 85% 81% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101248.06377
GSM201543Muscle PCOS pioglitazone 121233.03476
GSM201544Muscle PCOS pioglitazone 161250.57476
GSM201545Muscle PCOS pioglitazone 201304.89481
GSM201829Muscle PCOS pioglitazone 231256.24576
GSM201830Muscle PCOS pioglitazon 251277.43980
GSM201831Muscle PCOS pioglitazone 271265.53378
GSM201832Muscle PCOS pioglitazone 31252.22179
GSM201833Muscle PCOS pioglitazone 41292.88182
GSM201834Muscle PCOS pioglitazone 81274.26779
GSM201835Muscle PCOS after pioglitazone 102295.17282
GSM201836Muscle PCOS after pioglitazone 122305.83283
GSM201837Muscle PCOS after pioglitazone 162260.51280
GSM201838Muscle PCOS after pioglitazone 202280.90780
GSM201839Muscle PCOS after pioglitazone 232294.53781
GSM201840Muscle PCOS after pioglitazone 252335.45983
GSM201841Muscle PCOS after pioglitazone 272289.62882
GSM201842Muscle PCOS after pioglitazone 32346.01187
GSM201843Muscle PCOS after pioglitazone 42333.53485
GSM201844Muscle PCOS after pioglitazone 82302.94681